Global Breast Cancer Therapeutics Market to Capitalize on R&D Activities Underway for Developing Novel Treatment Modalities
According to the World Health Organization (WHO) breast cancer has been the leading cancer type killing women aged between 20 years and 59 years. As per the findings of the World Cancer Research Fund International, breast cancer accounts for 12% of all new cancer cases diagnosed globally, and 25% of all cancer cases in women. Furthermore, the American Cancer Society has stated that by the end of 2015 there will be more than 231,000 new cases of breast cancer diagnosed in the U.S. alone. While the disease has become prevalent enough to effect the lives of millions of families around the world, relentless research to find an effective cure for inhibiting the prevalence of this chronic ailment is already underway. Global Breast Cancer Market to Exhibit 8.3% CAGR during 2015-2023 The treatment administered to patients diagnosed with breast cancer has substantially evolved in the last few years. The growing use of targeted therapy has also helped in lowering the mor...